Although there has been no investigation into the effect of chemical USP7 inhibitors in melanoma cells, the USP7 inhibitors FT827 and FT671 showed high potency for suppressing USP7 activity in breast cancer cells [146]. Here, USP7 is linked to breast carcinoma.